Dkn-01 treated patients with recurrent epithelial endometrial (EEC) or ovarian (EOC) cancers which harbor Wnt activating mutations have longer progression-free survival and improved clinical benefit

Volume: 159, Pages: 5 - 6
Published: Oct 1, 2020
Abstract
Objective: Dickkopf-1 (DKK1) is a secreted modulator of Wnt signaling that promotes tumor cell proliferation, angiogenesis, and metastasis and contributes to an immune suppressive tumor microenvironment. Activating mutations of the Wnt/Beta-catenin dependent signaling pathway result in increased tumor production of DKK1. We assessed whether patients whose tumors harbor Wnt-activating mutations have improved clinical outcomes to DKN-01 (DKK1...
Paper Details
Title
Dkn-01 treated patients with recurrent epithelial endometrial (EEC) or ovarian (EOC) cancers which harbor Wnt activating mutations have longer progression-free survival and improved clinical benefit
Published Date
Oct 1, 2020
Volume
159
Pages
5 - 6
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.